STAT3 and cancer: We also observed that treatments inhibiting some of pro‐survival pathways (i.e., STAT3) may lead to the activation of p53 apoptotic program in PEL cells,17, 18 confirming previous studies indicating that STAT3 and p53, that have opposite function in cancer survival, can inhibit each other.19, 20